AN EORTC GASTROINTESTINAL GROUP EVALUATION OF THE COMBINATION OF SEQUENTIAL METHOTREXATE AND 5-FLUOROURACIL, COMBINED WITH ADRIAMYCIN IN ADVANCED MEASURABLE GASTRIC-CANCER

被引：116

作者：

WILS, J

BLEIBERG, H

DALESIO, O

BLIJHAM, G

MULDER, N

PLANTING, A

SPLINTER, T

DUEZ, N

机构：

[1] LAURENTIUS HOSP, 6043 CV ??? 6043 CV, NETHERLANDS

[2] INST JULES BORDET, B-1000 BRUSSELS, BELGIUM

[3] UNIV HOSP ANNADAL, MAASTRICT, NETHERLANDS

[4] STATE UNIV GRONINGEN HOSP, 9700 RB GRONINGEN, NETHERLANDS

[5] ERASMUS UNIV, 3000 DR ROTTERDAM, NETHERLANDS

[6] EUROPEAN ORG RES TREATMENT CANC, CTR DATA, BRUSSELS, BELGIUM

[7] DR DANIEL DENHOED CANC CTR, ROTTERDAM, NETHERLANDS

来源：

关键词：

D O I：

10.1200/JCO.1986.4.12.1799

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1799 / 1803

页数：5

共 22 条

[1] [Anonymous], 1979, WHO HDB REPORTING RE, V48
[2] BERTINO JR, 1977, CANCER RES, V37, P327
[3] BROWMAN GP, 1984, CANCER TREAT REP, V68, P465
[4] ENHANCED 5-FLUOROURACIL NUCLEOTIDE FORMATION AFTER METHOTREXATE ADMINISTRATION - EXPLANATION FOR DRUG SYNERGISM
CADMAN, E
HEIMER, R
DAVIS, L
[J]. SCIENCE, 1979, 205 (4411) : 1135 - 1137
[5] A COMPARISON OF 3 CHEMOTHERAPEUTIC REGIMENS IN THE TREATMENT OF ADVANCED PANCREATIC AND GASTRIC-CARCINOMA - FLUOROURACIL VS FLUOROURACIL AND DOXORUBICIN VS FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN
CULLINAN, SA
MOERTEL, CG
FLEMING, TR
RUBIN, JR
KROOK, JE
EVERSON, LK
WINDSCHITL, HE
TWITO, DI
MARSCHKE, RF
FOLEY, JF
PFEIFLE, DM
BARLOW, JF
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (14): : 2061 - 2067
[6] FAM THERAPY FOR ADVANCED GASTRIC-CANCER - AN IDEAL STANDARD
CULLINAN, SA
MOERTEL, CG
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) : 887 - 888
[7] CUNNINGHAM D, 1985, CANCER TREAT REP, V69, P927
[8] DOUGLASS HO, 1985, J CLIN ONCOL, V3, P888
[9] AN EASTERN COOPERATIVE ONCOLOGY GROUP EVALUATION OF COMBINATIONS OF METHYL-CCNU, MITOMYCIN-C, ADRIAMYCIN, AND 5-FLUOROURACIL IN ADVANCED MEASURABLE GASTRIC-CANCER (EST-2277)
DOUGLASS, HO
LAVIN, PT
GOUDSMIT, A
KLAASSEN, DJ
PAUL, AR
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (12) : 1372 - 1381
[10] EVANS RM, 1981, CANCER RES, V41, P3288